Table:
begin	end	state
1	12	cytoplasmic
13	35	transmembrane
36	41	non-cytoplasmic
42	60	transmembrane
61	80	cytoplasmic
81	102	transmembrane
103	121	non-cytoplasmic
122	140	transmembrane
141	150	cytoplasmic
151	172	transmembrane
173	191	non-cytoplasmic
192	216	transmembrane
217	236	cytoplasmic
237	256	transmembrane
257	276	non-cytoplasmic
277	297	transmembrane
298	329	cytoplasmic
330	349	transmembrane
350	354	non-cytoplasmic
355	379	transmembrane
380	392	cytoplasmic
393	414	transmembrane
415	419	non-cytoplasmic
420	439	transmembrane
440	453	cytoplasmic

Input:
>N515DRAFT_3653
MTQHLQRRLTPRHITFMALGMAIGAGLFLGSANAINLAGPSVLFAYLFGGAMIFIIMRAL
GEMAVHDPVAGSFSTYAHRYLGPFAGYLTGWNYWILMVGVGMAESTAVGIYMRQWFPELP
QWIWVFGSVAMIGGLNLMAVKVYGEMEFWFTLIKVVTVVLMILGGAGMIWLGWGNGGQPV
GLANLWSHGGWFPHGFTGMVLALPVVVFAFGGIETIGMAAGEAAQPERTIPRAVNSVLWR
ILIFYVGALFVIMAIYPWDQLGTQGSPFVTTFGKLGIPQAAGLINFVVITAALSGFNSTT
FSGSRMLYSLSTKAQAPAFLGQVSEHGVPVRAVLVTLACLVFGVVLNYLLPERIFAMMMS
ILAFNTVWTWMMVLIAHYSFRRRHGATAFPLRAWPLTSVVCLLFLAFVLFMLGYSADTRV
ALYVGAGWVVLLSLAYRLLGIGARMRALEPRAI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server